首页> 外文OA文献 >NORTHERN MALAYSIA PULMONOLOGY CENTRE EXPERIENCE AND ANALYSIS OF PROGRESSION FREE SURVIVAL RATE WITH TYROSINE KINASE INHIBITORS IN MANAGING ADVANCED ADENOCARCINOMA OF LUNG

【2h】

NORTHERN MALAYSIA PULMONOLOGY CENTRE EXPERIENCE AND ANALYSIS OF PROGRESSION FREE SURVIVAL RATE WITH TYROSINE KINASE INHIBITORS IN MANAGING ADVANCED ADENOCARCINOMA OF LUNG

机译：马来西亚北部肺部中心经验和分析酪氨酸激酶抑制剂在治疗肺癌晚期腺癌中的进展

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. NORTHERN MALAYSIA PULMONOLOGY CENTRE EXPERIENCE AND ANALYSIS OF PROGRESSION FREE SURVIVAL RATE WITH TYROSINE KINASE INHIBITORS IN MANAGING ADVANCED ADENOCARCINOMA OF LUNG [J] . Alaga Arvindran, Pathi Nafiisah, Soelar Aiman, Respirology : . 2018,第Suppla2期

机译：北马来西亚肺部中心经验与酪氨酸激酶抑制剂在管理肺癌晚期腺癌中的自由生存率分析
2. Better Progression-Free Survival in Elderly Patients with Stage IV Lung Adenocarcinoma Harboring Uncommon Epidermal Growth Factor Receptor Mutations Treated with the First-line Tyrosine Kinase Inhibitors [J] . Ming-Ju Tsai, Jen-Yu Hung, Mei-Hsuan Lee, Cancers . 2018,第11期

机译：一线酪氨酸激酶抑制剂治疗具有罕见表皮生长因子受体突变的Ⅳ期肺腺癌老年患者更好的无进展生存期
3. Genetic Modifiers of Progression-Free Survival in Never-Smoking Lung Adenocarcinoma Patients Treated with First-Line Tyrosine Kinase Inhibitors [J] . I-Shou Chang, Shih Sheng Jiang, James Chih-Hsin Yang, American journal of respiratory and critical care medicine . 2017,第5期

机译：一线酪氨酸激酶抑制剂治疗的非吸烟肺腺癌患者无进展生存的遗传修饰因子
4. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy [C] . Jiangdian Song, Di Dong, Yanqi Huang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
5. Predictive Biomarkers of the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treating Advanced Non-small Cell Lung Cancer: A Systematic Review of Randomized Controlled Trials [D] . Yang, Zuyao. 2014

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物：随机对照试验的系统评价。
6. Better Progression-Free Survival in Elderly Patients with Stage IV Lung Adenocarcinoma Harboring Uncommon Epidermal Growth Factor Receptor Mutations Treated with the First-line Tyrosine Kinase Inhibitors [O] . Ming-Ju Tsai, Jen-Yu Hung, Mei-Hsuan Lee, 2018

机译：老年患者阶段IV肺腺癌患者的更好的进展生存率涉及用一线酪氨酸激酶抑制剂处理的罕见表皮生长因子受体突变

NORTHERN MALAYSIA PULMONOLOGY CENTRE EXPERIENCE AND ANALYSIS OF PROGRESSION FREE SURVIVAL RATE WITH TYROSINE KINASE INHIBITORS IN MANAGING ADVANCED ADENOCARCINOMA OF LUNG

著录项

相似文献

相关主题

期刊订阅